Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{184564,
        author = {Neeta Verma and Aditi Tripathi and Abhash Kumar and Deep Das},
        title = {Current Regulatory Landscape Reviews: Evolving Pharmacovigilance Systems, Comparative Frameworks, and the Role of Real-World Evidence in India},
        journal = {International Journal of Innovative Research in Technology},
        year = {2025},
        volume = {12},
        number = {4},
        pages = {3147-3160},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=184564},
        abstract = {},
        keywords = {Index Terms— Pharmacovigilance Programme of India (PvPI), Central Drugs Standard Control Organization (CDSCO), European Medicines Agency (EMA), Adverse Drug Reactions (ADRs), Real-World Evidence (RWE), Post-Marketing Surveillance (PMS), Regulatory Harmonisation, Digital Health, Drug Safety},
        month = {September},
        }